{"SPADE_UN_17635": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17635", "Peptide Name": "2D5(G45-Y51)", "Source": "Synthetic (STAP-2 PH domain–derived peptide)", "Family": "", "Gene": "Not found", "Sequence": "RRRRRRRRGGGLTIYFY", "Sequence Length": 17, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "EGFR", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C97H163N41O21", "Mass": 2239.59, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -1.73, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Comments": "STAP-2 PH domain–derived peptide inhibited STAP-2–EGFR interaction and suppressed EGFR-mediated proliferation in several cancer cell lines.", "Literature": [{"Title": "A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling", "Pubmed ID": "36410436", "Reference": "J Biol Chem. 2023 Jan;299(1)102731.", "Author": "Maemoto T, Kitai Y, Takahashi R, Shoji H, Yamada S, Takei S, Ito D, Muromoto R, Kashiwakura JI, Handa H, Hashimoto A, Hashimoto S, Ose T, Oritani K, Matsuda T.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=36410436"}], "Frequent Amino Acids": "RGY", "Absent Amino Acids": "ACDEHKMNOPQSUVW", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 11, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_10932", "Similarity": 1.0, "Sequence": "RRR"}, {"SPADE_ID": "SPADE_N_11097", "Similarity": 1.0, "Sequence": "WWRRRRRRRR"}, {"SPADE_ID": "SPADE_N_11098", "Similarity": 1.0, "Sequence": "WWWRRRRRRRR"}]}}}